Exosome Bone Graft Composition for Preserving Vesicle Integrity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Exosomes are fragile vesicles that require a suitable environment to maintain their integrity for therapeutic use in bone graft compositions, and existing bone graft materials do not effectively preserve their structure and functionality.
Innovation Solution
A bone graft material comprising an exosome mixture with dimethyl sulfoxide, epsilon poly L-lysine, and natural or man-made bone materials, which maintains the integrity and functionality of exosomes and liposomes, preventing clumping and degradation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If exosomes are used in bone graft compositions, then therapeutic efficacy for bone regeneration is improved, but exosome integrity and stability deteriorate due to their fragile nature
Solution Approach 1:
The patent uses dimethyl sulfoxide (DMSO) as a protective intermediary substance that surrounds and stabilizes exosomes during storage and transport. DMSO forms a protective environment that prevents exosome degradation while maintaining their therapeutic functionality, effectively mediating between the fragile exosomes and the external environment.
Solution Approach 2:
The patent modifies the physical and chemical parameters of the storage environment by controlling temperature, pH, and using DMSO as a cryoprotectant. These parameter changes create optimal conditions for exosome stability without compromising their therapeutic efficacy, allowing long-term preservation of exosome integrity.
2Stability of the object's composition
If exosomes are stored in a suitable environment, then exosome integrity is maintained, but therapeutic application and bone regeneration capability are limited
Solution Approach 1:
DMSO serves as a mediator that allows exosomes to maintain integrity during storage while preserving their ability to promote bone regeneration. The intermediary protects exosomes without interfering with their biological function, enabling both stability and therapeutic productivity.
Solution Approach 2:
The patent performs preliminary stabilization of exosomes using DMSO and controlled storage conditions before therapeutic application. This preliminary action ensures exosomes remain intact and functional when needed for bone regeneration, preparing them in advance for optimal therapeutic effect.
3Strength
If existing bone graft materials are used, then structural support for bone growth is provided, but exosome preservation and functionality are not maintained
Solution Approach 1:
The patent creates a composite bone graft material that combines traditional structural bone graft components with exosomes suspended in DMSO. This composite structure provides both the mechanical strength and structural support of conventional bone grafts and the regenerative therapeutic benefits of protected exosomes, achieving both structural and functional requirements.
Solution Approach 2:
DMSO acts as an intermediary medium that allows exosomes to be integrated with structural bone graft materials while maintaining their functionality. The intermediary enables the coexistence of structural support and exosome preservation in a single composite system.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The exosome mixture enhances bone regeneration by providing a stable scaffold for new bone growth, extending or strengthening adjacent bone tissue, while preserving the therapeutic efficacy of exosomes and liposomes.
Implementation Method 1
dimethyl sulfoxide
Implementation Method 2
epsilon poly L-lysine
Data Source
AI summary
The present disclosure relates to exosome bone graft systems and compositions and preservative systems and compositions as well as methods of use and methods of manufacturing of them.